FDA's Biosimilars Meeting Management Should Improve After Reorg In New Drug Office

 
• By Sue Sutter
  
Football
The FDA met most of its performance goals under the first year of the BsUFA II agreement. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics